Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J. Lee, Gary A. Piazza, Wen‐Chi Chang et al.|Cancer Prevention Research|2021Cited by 19
Abstract 5165: Novel RAS inhibitors DC070-547 and ADT-006 potently and selectively inhibit the growth of pancreatic tumor cells harboring constitutively activated RAS by blocking RAS-effector binding and signalingTyler Mattox, Gary A. Piazza, Kevin J. Lee et al.|Cancer Research|2017Cited by 0
Abstract 5159: Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activityAntonio Ward, Adam B. Keeton, Xi Chen et al.|Cancer Research|2017Cited by 0
Supplemental Figure Legends from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J. Lee, Gary A. Piazza, Wen‐Chi Chang et al.|Unknown|2023Cited by 0
Supplemental Figure 4A from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J. Lee, Gary A. Piazza, Wen‐Chi Chang et al.|Unknown|2023Cited by 0